<DrugInformationSummary id="CDR0000803954"><DrugInfoMetaData><DrugInfoType>Brief</DrugInfoType><DrugInfoAudience>Patients</DrugInfoAudience><DrugInfoDescription>This page contains brief information about tepotinib hydrochloride
         and a collection of links to more information about the use of 
         this drug, research results, and ongoing clinical trials.</DrugInfoDescription><DrugInfoURL xref="https://www.cancer.gov/about-cancer/treatment/drugs/tepotinibhydrochloride">Tepotinib Hydrochloride</DrugInfoURL><FDAApproved>Yes</FDAApproved><TerminologyLink ref="CDR0000660212">tepotinib hydrochloride</TerminologyLink><GlossaryLink ref="CDR0000803952">tepotinib hydrochloride</GlossaryLink><USBrandNames><USBrandName>Tepmetko</USBrandName></USBrandNames><PronunciationInfo><TermPronunciation>teh-POH-tih-nib HY-droh-KLOR-ide</TermPronunciation><MediaLink ref="CDR0000805379" type="audio/mpeg" alt="" language="en" id="_3"/><MediaLink ref="CDR0000805380" type="audio/mpeg" alt="" language="es" id="_4"/></PronunciationInfo><FDAExternalRef xref="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=80a0f1b9-071a-47f5-9e67-32d638a669dc&amp;audience=consumer">FDA label information for this drug is available at DailyMed.</FDAExternalRef></DrugInfoMetaData><DrugInfoTitle>Tepotinib Hydrochloride</DrugInfoTitle><Section id="_FDA"><Para><ExternalRef xref="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=80a0f1b9-071a-47f5-9e67-32d638a669dc&amp;audience=consumer">FDA label information for this drug is available at DailyMed.</ExternalRef></Para></Section><Section id="_5"><Title>Use in Cancer</Title>                                                              
  <Para id="_6">Tepotinib hydrochloride
         is approved to treat:</Para>                          
  <ItemizedList Style="bullet" id="_3">
   
   <ListItem><Strong><GlossaryTermRef href="CDR0000045323" dictionary="Cancer.gov" audience="Patient">Non-small cell lung cancer</GlossaryTermRef></Strong> that has an abnormal <GeneName><GlossaryTermRef href="CDR0000794425" dictionary="Cancer.gov" audience="Patient">MET</GlossaryTermRef></GeneName> gene.  It is used in adults whose cancer has spread to other parts of the body.</ListItem>
   </ItemizedList>
  <Para id="_7">Tepotinib hydrochloride
         is also being studied in the treatment of other types of
         cancer.</Para>
 </Section><Section id="_About"><Title>More About Tepotinib Hydrochloride</Title><Para id="_Dict_1"><ExternalRef xref="https://www.cancer.gov/publications/dictionaries/cancer-drug/def/660212">Definition from the NCI Drug Dictionary</ExternalRef> - Detailed scientific definition and other names for this drug.</Para></Section><Section id="_Research"><Title>Research Results and Related Resources</Title><Para><ExternalRef xref="https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies">Targeted Therapy to Treat Cancer</ExternalRef></Para></Section><Section id="_ClinicalTrial_1"><Title>Clinical Trials Accepting Patients</Title><Para id="_ClinicalTrial_2"><ExternalRef xref="https://www.cancer.gov/research/participate/clinical-trials/intervention/C171761">Find Clinical Trials for Tepotinib Hydrochloride</ExternalRef> - Check for trials from NCI's list of cancer clinical trials now accepting patients.</Para></Section> 
  <DrugInfoDisclaimer>


<Para id="_Disclaimer_4"><Strong>Important: </Strong>The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.
</Para></DrugInfoDisclaimer> 
  <DateFirstPublished>2021-03-11</DateFirstPublished><DateLastModified>2024-02-16</DateLastModified></DrugInformationSummary>
